Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	2.07B
Revenue (ttm)	2.37B
Net Income (ttm)	-1.12B
Shares Out	n/a
EPS (ttm)	-2.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	5,296
Open	5.20
Previous Close	5.25
Day's Range	5.20 - 5.20
52-Week Range	1.99 - 4.50
Beta	0.54
RSI	66.88
Earnings Date	Jan 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical anti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 4,980
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

In 2023, Sumitomo Pharma's revenue was 314.56 billion, a decrease of -43.38% compared to the previous year's 555.54 billion. Losses were -314.97 billion, 322.7% more than in 2022.

Financial numbers in JPY